---
figid: PMC5864529__nihms935205f1
figlink: /pmc/articles/PMC5864529/figure/F1/
number: F1
caption: 'Androgen synthesis is catalyzed by the enzyme CYP17. Binding of androgens
  to AR causes dissociation from HSP and AR dimerization. AR dimers translocate to
  the nucleus, associate with coregulatory proteins, and initiate transcription. In
  TNBC, AR signaling promotes cancer progression, and this can be blocked at various
  stages with pharmacological inhibitors (yellow). Cross-talk between AR and other
  signaling pathways is being used to establish rational drug combinations that are
  currently being explored for their effectiveness. Interconnecting lines are indicative
  of overall effects, positive or negative, on pathway activation. Abbreviations:
  AKT, protein kinase B; AR, androgen receptor; CREB, cAMP response element-binding
  protein; CYP17, cytochrome P450 17; EMT, epithelial-to-mesenchymal transition; ERK,
  extracellular signal-regulated kinase; HSP, heat shock protein; JAK, Janus kinase;
  PI3K, phosphatidylinositide 3-kinase; mTOR, mechanistic target of rapamycin; STAT,
  signal transducer and activator of transcription; TNBC, triple-negative breast cancer'
pmcid: PMC5864529
papertitle: 'Harnessing a different dependency: How to identify and target androgen
  receptor-positive versus quadruple-negative breast cancer.'
reftext: Jessica L. Christenson, et al. Horm Cancer. ;9(2):82-94.
pmc_ranked_result_index: '1648'
pathway_score: 0.9339367
filename: nihms935205f1.jpg
figtitle: AR signaling and therapeutic interventions in TNBC
year: ''
organisms:
- Mus musculus
- Rattus norvegicus
- Mouse mammary tumor virus
- Homo sapiens
ndex: ba6f4cb5-df08-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5864529__nihms935205f1.html
  '@type': Dataset
  description: 'Androgen synthesis is catalyzed by the enzyme CYP17. Binding of androgens
    to AR causes dissociation from HSP and AR dimerization. AR dimers translocate
    to the nucleus, associate with coregulatory proteins, and initiate transcription.
    In TNBC, AR signaling promotes cancer progression, and this can be blocked at
    various stages with pharmacological inhibitors (yellow). Cross-talk between AR
    and other signaling pathways is being used to establish rational drug combinations
    that are currently being explored for their effectiveness. Interconnecting lines
    are indicative of overall effects, positive or negative, on pathway activation.
    Abbreviations: AKT, protein kinase B; AR, androgen receptor; CREB, cAMP response
    element-binding protein; CYP17, cytochrome P450 17; EMT, epithelial-to-mesenchymal
    transition; ERK, extracellular signal-regulated kinase; HSP, heat shock protein;
    JAK, Janus kinase; PI3K, phosphatidylinositide 3-kinase; mTOR, mechanistic target
    of rapamycin; STAT, signal transducer and activator of transcription; TNBC, triple-negative
    breast cancer'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3R3
  - CREB3L2
  - CREB3L4
  - STAT1
  - PIK3R4
  - PIK3CG
  - PIK3CB
  - ATF1
  - CREB5
  - PIK3CA
  - STAT3
  - PIK3CD
  - CREB1
  - STAT2
  - CREM
  - PIK3R6
  - PIK3R5
  - STAT4
  - ATF2
  - CREB3L3
  - CREB3L1
  - STAT6
  - AKT2
  - AKT3
  - AKT1
  - MAPK1
  - JAK3
  - CREB3
  - MTOR
  - STAT5B
  - JAK2
  - AR
  - CYP17A1
  - STAT5A
  - MAPK3
  - TYK2
  - JAK1
  - Tyrosine
  - Androgen
  - Abiraterone
  - Bicalutamide
  - Enzalutamide
  - Stemness
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L2
  entrez: '64764'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L4
  entrez: '148327'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF1
  entrez: '466'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB5
  entrez: '9586'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB1
  entrez: '1385'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREM
  entrez: '1390'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF2
  entrez: '1386'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L3
  entrez: '84699'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L1
  entrez: '90993'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3
  entrez: '10488'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: AR
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
- word: CYP17
  symbol: CYP17
  source: hgnc_prev_symbol
  hgnc_symbol: CYP17A1
  entrez: '1586'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
chemicals:
- word: Tyrosine
  source: ''
  identifier: ''
- word: Androgen
  source: MESH
  identifier: D000728
- word: Abiraterone
  source: MESH
  identifier: C089740
- word: Bicalutamide
  source: MESH
  identifier: C053541
- word: Enzalutamide
  source: MESH
  identifier: C540278
diseases:
- word: Stemness
  source: MESH
  identifier: D020295
figid_alias: PMC5864529__F1
redirect_from: /figures/PMC5864529__F1
figtype: Figure
---
